Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets

<p>Company to receive $2 million in upfront payments, with the potential to receive up to $50 million in milestone payments and single digit royalty payments on future net sales SAN FRANCISCO, July 27, 2023 (GLOBE NEWSWIRE) — Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that it has entered into an Asset […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/titan-pharmaceuticals-announces-sale-of-certain-proneura-assets/">Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>